Research ExplorerPublicationsTreatment Satisfaction in Psoriasis: Development and Use of ...

Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study

Standard

Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study. / Radtke, Marc Alexander; Spehr, Christina; Reich, Kristian; Rustenbach, Stephan J; Kisch, Julia; Augustin, Matthias.

In: DERMATOLOGY, Vol. 232, No. 3, 2016, p. 334-343.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Radtke, MA, Spehr, C, Reich, K, Rustenbach, SJ, Kisch, J & Augustin, M 2016, 'Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study', DERMATOLOGY, vol. 232, no. 3, pp. 334-343. https://doi.org/10.1159/000444635

APA

Radtke, M. A., Spehr, C., Reich, K., Rustenbach, S. J., Kisch, J., & Augustin, M. (2016). Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study. DERMATOLOGY, 232(3), 334-343. https://doi.org/10.1159/000444635

Vancouver

Radtke MA, Spehr C, Reich K, Rustenbach SJ, Kisch J, Augustin M. Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study. DERMATOLOGY. 2016;232(3):334-343. https://doi.org/10.1159/000444635

Bibtex

@article{473ae21dd977481db4204b379fb82da0,
title = "Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study",
abstract = "INTRODUCTION: Evidence supports the potential value of matching patient preferences to treatment recommendations. The aim of the study was to design and validate a questionnaire on treatment satisfaction for clinical decision-making.METHODS: We performed a comprehensive literature search identifying measurable indicators. The complete item pool was condensed to a core set by a multidisciplinary expert panel and tested in a multicentre, observational, cross-sectional study.RESULTS: The questionnaire consisted of 8 questions, rated on a 5-point Likert scale. In total, 213 dermatology centres included 2,084 patients. The mean disease duration was 19 years. A majority of patients (82.8%) was moderately to very satisfied. 108 patients (5.8%) felt to be bothered by side effects, and 32.1% ascertained that the current therapy had been conducted for too long without success.DISCUSSION: The PsoSat Questionnaire was shown to be a reliable and valid instrument for measuring therapy-related satisfaction. Further research on its implementation in clinical decision-making is necessary to finally evaluate the benefit of this tool.",
keywords = "Journal Article",
author = "Radtke, {Marc Alexander} and Christina Spehr and Kristian Reich and Rustenbach, {Stephan J} and Julia Kisch and Matthias Augustin",
note = "Julia Feuerhahn hei{\ss}t mittlerweile Julia Kisch und ist interne Mitarbeiterin.",
year = "2016",
doi = "10.1159/000444635",
language = "English",
volume = "232",
pages = "334--343",
journal = "DERMATOLOGY",
issn = "1018-8665",
publisher = "S. Karger AG",
number = "3",

}

RIS

TY - JOUR

T1 - Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study

AU - Radtke, Marc Alexander

AU - Spehr, Christina

AU - Reich, Kristian

AU - Rustenbach, Stephan J

AU - Kisch, Julia

AU - Augustin, Matthias

N1 - Julia Feuerhahn heißt mittlerweile Julia Kisch und ist interne Mitarbeiterin.

PY - 2016

Y1 - 2016

N2 - INTRODUCTION: Evidence supports the potential value of matching patient preferences to treatment recommendations. The aim of the study was to design and validate a questionnaire on treatment satisfaction for clinical decision-making.METHODS: We performed a comprehensive literature search identifying measurable indicators. The complete item pool was condensed to a core set by a multidisciplinary expert panel and tested in a multicentre, observational, cross-sectional study.RESULTS: The questionnaire consisted of 8 questions, rated on a 5-point Likert scale. In total, 213 dermatology centres included 2,084 patients. The mean disease duration was 19 years. A majority of patients (82.8%) was moderately to very satisfied. 108 patients (5.8%) felt to be bothered by side effects, and 32.1% ascertained that the current therapy had been conducted for too long without success.DISCUSSION: The PsoSat Questionnaire was shown to be a reliable and valid instrument for measuring therapy-related satisfaction. Further research on its implementation in clinical decision-making is necessary to finally evaluate the benefit of this tool.

AB - INTRODUCTION: Evidence supports the potential value of matching patient preferences to treatment recommendations. The aim of the study was to design and validate a questionnaire on treatment satisfaction for clinical decision-making.METHODS: We performed a comprehensive literature search identifying measurable indicators. The complete item pool was condensed to a core set by a multidisciplinary expert panel and tested in a multicentre, observational, cross-sectional study.RESULTS: The questionnaire consisted of 8 questions, rated on a 5-point Likert scale. In total, 213 dermatology centres included 2,084 patients. The mean disease duration was 19 years. A majority of patients (82.8%) was moderately to very satisfied. 108 patients (5.8%) felt to be bothered by side effects, and 32.1% ascertained that the current therapy had been conducted for too long without success.DISCUSSION: The PsoSat Questionnaire was shown to be a reliable and valid instrument for measuring therapy-related satisfaction. Further research on its implementation in clinical decision-making is necessary to finally evaluate the benefit of this tool.

KW - Journal Article

U2 - 10.1159/000444635

DO - 10.1159/000444635

M3 - SCORING: Journal article

C2 - 27073875

VL - 232

SP - 334

EP - 343

JO - DERMATOLOGY

JF - DERMATOLOGY

SN - 1018-8665

IS - 3

ER -